Paul Schneider

Finanzdirektor/CFO bei FREELINE THERAPEUTICS HOLDINGS PLC

56 Jahre

Health Technology

Consumer Services

Profil

Paul M.
Schneider is currently the Chief Financial Officer at Freeline Therapeutics Holdings Plc.
Prior to his current position, he served as the Senior Vice President-Finance at Casebia Therapeutics LLC from 2016 to 2019.
He also held the position of Senior Vice President-Finance & Operations at Exo Therapeutics, Inc. Mr. Schneider completed his undergraduate degree at Boston College.

Aktive Positionen von Paul Schneider

Unternehmen	Position	Beginn
FREELINE THERAPEUTICS HOLDINGS PLC	Finanzdirektor/CFO	16.05.2022

Alle aktiven Positionen von Paul Schneider

Ehemalige bekannte Positionen von Paul Schneider

Unternehmen	Position	Ende
Casebia Therapeutics LLC Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease	Corporate Officer/Principal	01.09.2019
Exo Therapeutics, Inc. Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes	Finanzdirektor/CFO	-

Sehen Sie sich die Erfahrung von Paul Schneider im Detail an

Ausbildung von Paul Schneider

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul Schneider im Detail an

Unternehmensverbindungen

Private Unternehmen	4
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Casebia Therapeutics LLC Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease	Health Technology
Exo Therapeutics, Inc. Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes	Health Technology
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies	Health Technology